241
Views
4
CrossRef citations to date
0
Altmetric
Review

Treatment to target in patients with inflammatory bowel disease. What is the evidence?

, &
Pages 528-536 | Received 02 Feb 2020, Accepted 20 Apr 2020, Published online: 05 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Katrine Risager Christensen, Casper Steenholdt, Sine Buhl, Jørn Brynskov & Mark Andrew Ainsworth. (2022) A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients’ and physicians’ preferences and adherence. Scandinavian Journal of Gastroenterology 57:3, pages 274-281.
Read now

Articles from other publishers (3)

Wu Ronghua, Zheng Ji, Liu Gang, Zhang Yun & Nie Xubiao. (2024) Cystitis glandularis with concomitant Crohn’s disease leading to a paroxysm of Crohn’s disease with ulcerated external iliac vessels. BMC Urology 24:1.
Crossref
Jack West, Katrina Tan, Jalpa Devi, Finlay Macrae, Britt Christensen & Jonathan P. Segal. (2023) Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease. Journal of Clinical Medicine 12:19, pages 6292.
Crossref
Gerhard Rogler. (2022) No Need to Scope? Monitoring of Treatment Response in IBD Patients by Transabdominal Ultrasound. Journal of Crohn's and Colitis 16:4, pages 521-522.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.